SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

• 收藏
• 分享

专利权人:

BAYER INTELLECTUAL PROPERTY GMBH.

发明人:

HENTEMANN, MARTIN,WOOD, JILL,SCOTT, WILLIAM,MICHELS, MARTIN,CAMPBELL, ANN-MARIE,BULLION, ANN-MARIE,ROWLEY, R., BRUCE,REDMAN, ANIKO

申请号：

RSP20170561

公开号：

RS56045B1

申请日:

2007.12.05

申请国别(地区):

RS

年份:

2017

代理人:

摘要：

This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/